2-(3-methoxyphenyl)-1,4-dihydroquinazolin-4-one, 97%, 250mg

N-Succinimidyl 3-Maleimidobenzoate [Cross-linking Reagent]>98.0%(HPLC)(N)1g

Oxazol-2(3H)-one, 95.0%, 100mg

(+)-Biotin-(PEO)3-amine, 97.0%, 100mg

N-(9-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 98%, 5g

1-Ethylcyclopropanecarboxylic acid, 95.0%, 5g

4-acetylpiperazin-2-one, 95.0%, 10g

2-(Ethylsulfonyl)aniline, 95.0%, 10g

3-Phenylisoquinoline, 5g

4-Methyl-2-pyrrolidin-1-ylmethyl-piperazine-1-carboxylic acid benzyl ester, 95.0%, 250mg

5,6-Diaminonicotinic acid, 95.0%, 1g

(3s,5r)-3-Cyclopropyl-5-methyl-2-oxo-pyrrolidine-3-carbonitrile, 98%, 100mg

1-Phenylethanamine, 95.0%, 500g